Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Vertex Pharmaceuticals Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Vertex Pharmaceuticals Incorporated May 13, 202698.9%
-
Vertex Pharmaceuticals Incorporated May 14, 202598.7%
-
Vertex Pharmaceuticals Incorporated May 15, 202499.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 | Thermo Fisher Scientific Inc | Shares withheld for tax | −837 | $521.11 | $436,107 |
| Feb 28, 2026 | Thermo Fisher Scientific Inc | Shares withheld for tax | −360 | $521.11 | $187,459 |
| Feb 25, 2026 | Thermo Fisher Scientific Inc | Grant or award | +2,231 | — | — |
| Dec 4, 2025 | Thermo Fisher Scientific Inc | Option exercise | +18,637 | $105.17 | $1,960,053 |
| Dec 4, 2025 | Thermo Fisher Scientific Inc | Option exercise | +22,046 | $132.66 | $2,924,622 |
| Dec 4, 2025 | Thermo Fisher Scientific Inc | Open-market sale | −22,046 | $563.56 | $12,424,244 |
| Dec 3, 2025 | Thermo Fisher Scientific Inc | Option exercise | +68,000 | $105.17 | $7,151,560 |
| Dec 3, 2025 | Thermo Fisher Scientific Inc | Open-market sale | −29,479 | $583.33 | $17,195,985 |
| Dec 3, 2025 | Thermo Fisher Scientific Inc | Open-market sale | −2,521 | $584.11 | $1,472,541 |
| Dec 2, 2025 | Thermo Fisher Scientific Inc | Option exercise | +36,000 | $105.17 | $3,786,120 |
| Dec 2, 2025 | Thermo Fisher Scientific Inc | Open-market sale | −30,000 | $581.92 | $17,457,600 |
| Nov 13, 2025 | Thermo Fisher Scientific Inc | Option exercise | +4,638 | $253.99 | $1,178,006 |
| Nov 13, 2025 | Thermo Fisher Scientific Inc | Open-market sale | −4,638 | $594.42 | $2,756,920 |
| Aug 28, 2025 | Thermo Fisher Scientific Inc | Shares withheld for tax | −262 | $489.74 | $128,341 |
| Aug 28, 2025 | Thermo Fisher Scientific Inc | Shares withheld for tax | −262 | $489.74 | $128,341 |
Questions about Michel Lagarde
What boards is Michel Lagarde on?
Michel Lagarde sits on the boards of Vertex Pharmaceuticals Incorporated and West Pharmaceutical Services Inc.
What company is Michel Lagarde the CEO of?
Michel Lagarde has been President and CEO of West Pharmaceutical Services Inc. since August 2026.
How long has Michel Lagarde served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.